Letrozole is a medication used in the treatment of hormone receptor-positive breast cancer in postmenopausal women. It belongs to a class of

Letrozole is a medication that is commonly used in the treatment of hormone receptor-positive breast cancer in postmenopausal women. It belongs to a class of drugs called aromatase inhibitors, which work by lowering the levels of estrogen in the body. Estrogen is a hormone that can promote the growth of certain types of breast cancers. By reducing the amount of estrogen available, letrozole helps to slow down or stop the growth of these cancer cells.

Mode of Action of Letrozole

Letrozole, also known by its brand name Femara, is a medication primarily used for the treatment of breast cancer in postmenopausal women. It belongs to a class of drugs called aromatase inhibitors, which work by reducing the amount of estrogen produced in the body.

Estrogen, a hormone predominantly found in females, plays a crucial role in the growth and development of breast cancer cells. By inhibiting the production of estrogen, letrozole effectively slows down or stops the growth of hormone receptor-positive breast tumors, which require estrogen to grow.

Here is how letrozole works:

• Inhibition of Aromatase Enzyme: Letrozole works by blocking an enzyme called aromatase, which is responsible for converting the hormone androgen into estrogen. By inhibiting this enzyme, letrozole reduces the overall levels of estrogen in the body.
• Reduction of Estrogen Levels: By lowering estrogen levels, letrozole disrupts the hormonal balance required for the growth and survival of hormone receptor-positive breast cancer cells. This inhibition helps prevent cancer recurrence and improves the chances of successful treatment.
• Suppression of Tumor Growth: Letrozole’s mode of action directly affects the tumor cells themselves. By depriving them of estrogen, https://letrozole-for-sale.com/ it suppresses their ability to divide and grow. This can lead to a decrease in tumor size and ultimately inhibit the spread of cancer.
• Complementary Therapy: Letrozole is commonly used as an adjuvant therapy, meaning it is given after surgery or other primary treatments to reduce the risk of cancer recurrence. It may also be used as a neoadjuvant therapy to shrink tumors before surgery or radiation therapy.

Letrozole is generally well-tolerated, but it can have side effects such as hot flashes, joint pain, fatigue, and increased risk of osteoporosis. It is important to discuss any concerns or potential side effects with a healthcare professional.

In conclusion, letrozole’s mode of action involves inhibiting the aromatase enzyme, reducing estrogen levels, suppressing tumor growth, and serving as a complementary therapy in the treatment of hormone receptor-positive breast cancer.